MarketPulse
D

$DHR

8 articles found
7 positive
0 negative
1 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Custom Market Insights

Pharma QC Testing Market to Reach $17.65B by 2035 on AI, Automation Surge

Global pharmaceutical microbiology QC testing market projected to grow from $5.08B in 2025 to $17.65B by 2035, driven by automation and AI adoption.
TMODHRCRLMKKGYBDX+2regulatory compliancemarket forecast
GlobeNewswire Inc.GlobeNewswire Inc.··Mordor Intelligence

Molecular Diagnostics Market Poised for Double-Digit Growth Through 2031

Global molecular diagnostics market projected to reach $33.51B by 2031 at 10.43% CAGR, driven by precision medicine adoption and genomic testing advances.
ILMNABTRHHBYTMODHR+6healthcare technologyprecision medicine
GlobeNewswire Inc.GlobeNewswire Inc.··Custom Market Insights

Microplate Systems Market to Double to $2.88B by 2035 on Biotech Boom

Global microplate systems market projected to grow from $1.42B (2025) to $2.88B (2035) at 10.7% CAGR, driven by pharma R&D spending and automation demand.
TMODHRGLWABIO+2automationmarket growth
GlobeNewswire Inc.GlobeNewswire Inc.··Mordor Intelligence

Precision Medicine Market Set to Double by 2031 on AI and Biomarker Advances

Precision medicine market expected to double to $237.28B by 2031, driven by AI advances and biomarker development at 13.58% annual growth.
ILMNABTRHHBYTMODHRAI integrationprecision medicine
BenzingaBenzinga··Prnewswire

Danaher Raises Quarterly Dividend to $0.40 Per Share

Danaher raises quarterly dividend to $0.40 per share, payable April 24, 2026, reflecting strong financial position and commitment to shareholder returns.
DHRdividendshareholder returns
BenzingaBenzinga··Caroline Ryan

Wave of Major Acquisitions Reshapes Healthcare, Travel, and Energy Sectors

Major M&A wave reshapes industries: Danaher acquires Masimo for $9.9B, Devon completes $21.4B energy merger, while Starboard pressures TripAdvisor toward sale.
WBDHIMSDHRMCWTRIP+2healthcareprivate equity
BenzingaBenzinga··Vandana Singh

Danaher to Acquire Masimo for $9.9B in Cash Deal

Danaher acquires Masimo for $9.9 billion in cash, expanding its medical technology portfolio with expected synergies exceeding $175 million annually.
DHRMASIacquisitionM&A
BenzingaBenzinga··Vandana Singh

Danaher to Acquire Masimo for $9.9B in Healthcare Technology Deal

Danaher to acquire Masimo for $9.9 billion, expanding its healthcare technology portfolio. The deal represents a significant premium and major consolidation in medical devices.
AAPLDHRMASIacquisitionstock surge